chr15-51893854-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP3BP4BS2
The NM_014547.5(TMOD3):āc.536A>Gā(p.Glu179Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000861 in 1,609,160 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00051 ( 0 hom., cov: 33)
Exomes š: 0.00090 ( 2 hom. )
Consequence
TMOD3
NM_014547.5 missense
NM_014547.5 missense
Scores
7
8
4
Clinical Significance
Conservation
PhyloP100: 8.48
Genes affected
TMOD3 (HGNC:11873): (tropomodulin 3) Enables cadherin binding activity involved in cell-cell adhesion. Predicted to be involved in actin filament organization; muscle contraction; and myofibril assembly. Predicted to act upstream of or within actin cytoskeleton organization; erythrocyte development; and positive regulation of mitotic cell cycle phase transition. Located in adherens junction. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PP3
Multiple lines of computational evidence support a deleterious effect 7: Cadd, Dann, Eigen, FATHMM_MKL, MutationAssessor, phyloP100way_vertebrate, PROVEAN [when BayesDel_addAF, max_spliceai, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.3723658).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMOD3 | NM_014547.5 | c.536A>G | p.Glu179Gly | missense_variant | 6/10 | ENST00000308580.12 | NP_055362.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMOD3 | ENST00000308580.12 | c.536A>G | p.Glu179Gly | missense_variant | 6/10 | 1 | NM_014547.5 | ENSP00000308753 | P1 | |
TMOD3 | ENST00000560549.5 | c.119A>G | p.Glu40Gly | missense_variant, NMD_transcript_variant | 4/12 | 1 | ENSP00000454040 | |||
ENST00000558142.1 | n.229-1376T>C | intron_variant, non_coding_transcript_variant | 3 | |||||||
TMOD3 | ENST00000561438.5 | c.41A>G | p.Glu14Gly | missense_variant, NMD_transcript_variant | 1/8 | 5 | ENSP00000452939 |
Frequencies
GnomAD3 genomes AF: 0.000506 AC: 77AN: 152206Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
77
AN:
152206
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000521 AC: 130AN: 249716Hom.: 0 AF XY: 0.000489 AC XY: 66AN XY: 135054
GnomAD3 exomes
AF:
AC:
130
AN:
249716
Hom.:
AF XY:
AC XY:
66
AN XY:
135054
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000898 AC: 1308AN: 1456836Hom.: 2 Cov.: 33 AF XY: 0.000834 AC XY: 604AN XY: 724324
GnomAD4 exome
AF:
AC:
1308
AN:
1456836
Hom.:
Cov.:
33
AF XY:
AC XY:
604
AN XY:
724324
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000506 AC: 77AN: 152324Hom.: 0 Cov.: 33 AF XY: 0.000497 AC XY: 37AN XY: 74488
GnomAD4 genome
AF:
AC:
77
AN:
152324
Hom.:
Cov.:
33
AF XY:
AC XY:
37
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
5
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
10
ExAC
AF:
AC:
58
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.536A>G (p.E179G) alteration is located in exon 6 (coding exon 5) of the TMOD3 gene. This alteration results from a A to G substitution at nucleotide position 536, causing the glutamic acid (E) at amino acid position 179 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at